Hector A - Search Results

1

International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net.

Chang AB, Boyd J, Bush A, Hill AT, Powell Z, Zacharasiewicz A, Alexopoulou E, Chalmers JD, Collaro AJ, Constant C, Douros K, Fortescue R, Griese M, Grigg J, Hector A, Karadag B, Mazulov O, Midulla F, Moeller A, Proesmans M, Wilson C, Yerkovich ST, Kantar A, Grimwood K. Chang AB, et al. Among authors: hector a. Eur Respir J. 2022 Jun 9;59(6):2200264. doi: 10.1183/13993003.00264-2022. Print 2022 Jun. Eur Respir J. 2022. PMID: 35680151 Free article. No abstract available.

2

Reply: glutathione inhalation treatments in cystic fibrosis: the interference of airway γ-glutamyltransferase.

Hector A, Griese M. Hector A, et al. Am J Respir Crit Care Med. 2014 Jan 15;189(2):234-5. doi: 10.1164/rccm.201307-1289LE. Am J Respir Crit Care Med. 2014. PMID: 24428658 No abstract available.

3

Oxidative stress in cystic fibrosis lung disease: an early event, but worth targeting?

Hector A, Griese M, Hartl D. Hector A, et al. Eur Respir J. 2014 Jul;44(1):17-9. doi: 10.1183/09031936.00038114. Eur Respir J. 2014. PMID: 24982050 Free article. No abstract available.

4

CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease.

Carevic M, Singh A, Rieber N, Eickmeier O, Griese M, Hector A, Hartl D. Carevic M, et al. Among authors: hector a. Eur Respir J. 2015 Aug;46(2):395-404. doi: 10.1183/09031936.00173514. Epub 2015 Apr 30. Eur Respir J. 2015. PMID: 25929952 Free article.

5

An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis.

Stanke F, Hector A, Hedtfeld S, Hartl D, Griese M, Tümmler B, Mall MA. Stanke F, et al. Among authors: hector a. Eur Respir J. 2017 Dec 28;50(6):1700426. doi: 10.1183/13993003.00426-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284683 Free article. No abstract available.

6

In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Hector A, Kappler M, Griese M. Hector A, et al. Mediators Inflamm. 2010;2010:809591. doi: 10.1155/2010/809591. Epub 2010 Jun 16. Mediators Inflamm. 2010. PMID: 20634941 Free PMC article.

7

The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease.

Hector A, Kröner C, Carevic M, Bakele M, Rieber N, Riethmüller J, Griese M, Zissel G, Hartl D. Hector A, et al. Eur Respir J. 2014 Dec;44(6):1608-15. doi: 10.1183/09031936.00070014. Epub 2014 Aug 19. Eur Respir J. 2014. PMID: 25142483 Free article.

8

Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione.

Corti A, Griese M, Hector A, Pompella A. Corti A, et al. Among authors: hector a. J Cyst Fibros. 2017 May;16(3):342-345. doi: 10.1016/j.jcf.2016.12.002. Epub 2016 Dec 14. J Cyst Fibros. 2017. PMID: 27988297 Free article. Clinical Trial.

9

Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells.

Weichert N, Kaltenborn E, Hector A, Woischnik M, Schams A, Holzinger A, Kern S, Griese M. Weichert N, et al. Among authors: hector a. Respir Res. 2011 Jan 7;12(1):4. doi: 10.1186/1465-9921-12-4. Respir Res. 2011. PMID: 21214890 Free PMC article.

10

The role of matrix metalloproteinases in cystic fibrosis lung disease.

Gaggar A, Hector A, Bratcher PE, Mall MA, Griese M, Hartl D. Gaggar A, et al. Among authors: hector a. Eur Respir J. 2011 Sep;38(3):721-7. doi: 10.1183/09031936.00173210. Epub 2011 Jan 13. Eur Respir J. 2011. PMID: 21233269 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page